These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 30791442)

  • 21. Mapping the selection, availability, price and affordability of essential medicines for mental health conditions at a global level.
    Todesco B; Ostuzzi G; Barbui C
    Epidemiol Psychiatr Sci; 2022 Apr; 31():e22. PubMed ID: 35438063
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Essential medicines for emergency care in Africa.
    Broccoli MC; Pigoga JL; Nyirenda M; Wallis L; Calvello Hynes EJ
    Emerg Med J; 2018 Jul; 35(7):412-419. PubMed ID: 29627770
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical standards for the diagnosis and management of asthma in low- and middle-income countries.
    Jayasooriya S; Stolbrink M; Khoo EM; Sunte IT; Awuru JI; Cohen M; Lam DC; Spanevello A; Visca D; Centis R; Migliori GB; Ayuk AC; Buendia JA; Awokola BI; Del-Rio-Navarro BE; Muteti-Fana S; Lao-Araya M; Chiarella P; Badellino H; Somwe SW; Anand MP; Garcí-Corzo JR; Bekele A; Soto-Martinez ME; Ngahane BHM; Florin M; Voyi K; Tabbah K; Bakki B; Alexander A; Garba BL; Salvador EM; Fischer GB; Falade AG; ŽivkoviĆ Z; Romero-Tapia SJ; Erhabor GE; Zar H; Gemicioglu B; Brandão HV; Kurhasani X; El-Sharif N; Singh V; Ranasinghe JC; Kudagammana ST; Masjedi MR; Velásquez JN; Jain A; Cherrez-Ojeda I; Valdeavellano LFM; Gómez RM; Mesonjesi E; Morfin-Maciel BM; Ndikum AE; Mukiibi GB; Reddy BK; Yusuf O; Taright-Mahi S; Mérida-Palacio JV; Kabra SK; Nkhama E; Filho NR; Zhjegi VB; Mortimer K; Rylance S; Masekela RR
    Int J Tuberc Lung Dis; 2023 Sep; 27(9):658-667. PubMed ID: 37608484
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Updating the WHO Model Lists of Essential Medicines to promote global access to the most cost-effective and safe medicines for mental disorders.
    Papola D; Ostuzzi G; Todesco B; Gastaldon C; Hanna F; Chatterjee S; van Ommeren M; Barbui C
    Lancet Psychiatry; 2023 Oct; 10(10):809-816. PubMed ID: 37475123
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Analysis of evidence supporting the Federation of Bosnia and Herzegovina reimbursement medicines lists: role of the WHO Essential Medicines List, Cochrane systematic reviews and technology assessment reports.
    Mahmić-Kaknjo M; Marušić A
    Eur J Clin Pharmacol; 2015 Jul; 71(7):825-33. PubMed ID: 25956715
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Improving access to affordable quality-assured inhaled medicines in low- and middle-income countries.
    Stolbrink M; Chinouya MJ; Jayasooriya S; Nightingale R; Evans-Hill L; Allan K; Allen H; Balen J; Beacon T; Bissell K; Chakaya J; Chiang CY; Cohen M; Devereux G; El Sony A; Halpin DMG; Hurst JR; Kiprop C; Lawson A; Macé C; Makhanu A; Makokha P; Masekela R; Meme H; Khoo EM; Nantanda R; Pasternak S; Perrin C; Reddel H; Rylance S; Schweikert P; Were C; Williams S; Winders T; Yorgancioglu A; Marks GB; Mortimer K
    Int J Tuberc Lung Dis; 2022 Nov; 26(11):1023-1032. PubMed ID: 36281039
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Assessing variation among the national essential medicines lists of 21 high-income countries: a cross-sectional study.
    Taglione MS; Persaud N
    BMJ Open; 2021 Aug; 11(8):e045262. PubMed ID: 34380717
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of antibiotics included in national essential medicines lists of 138 countries using the WHO Access, Watch, Reserve (AWaRe) classification: a cross-sectional study.
    Adekoya I; Maraj D; Steiner L; Yaphe H; Moja L; Magrini N; Cooke G; Loeb M; Persaud N
    Lancet Infect Dis; 2021 Oct; 21(10):1429-1440. PubMed ID: 34332706
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Standard technical specifications for methacholine chloride (Methacholine) bronchial challenge test (2023)].
    ; ;
    Zhonghua Jie He He Hu Xi Za Zhi; 2024 Feb; 47(2):101-119. PubMed ID: 38309959
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Essential medicines are more available than other medicines around the globe.
    Bazargani YT; Ewen M; de Boer A; Leufkens HG; Mantel-Teeuwisse AK
    PLoS One; 2014; 9(2):e87576. PubMed ID: 24533058
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anticancer medicines in Pakistan: An analysis of essential medicines lists.
    Shukar S; Anjum R; Zhang J; Babar ZU; Mobeen I; Yang C
    J Oncol Pharm Pract; 2024 Jan; 30(1):46-54. PubMed ID: 37006130
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Challenges in updating national guidelines and essential medicines lists in Sub-Saharan African countries to include WHO-recommended postpartum hemorrhage medicines.
    Ng'ang'a J; Chitimbe T; Mburu R; Rushwan S; Ntirushwa D; Chinery L; Gülmezoglu AM
    Int J Gynaecol Obstet; 2022 Jun; 158 Suppl 1(Suppl 1):11-13. PubMed ID: 35762803
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Using the WHO essential medicines list to assess the appropriateness of insurance coverage decisions: a case study of the Croatian national medicine reimbursement list.
    Jeličić Kadić A; Žanić M; Škaričić N; Marušić A
    PLoS One; 2014; 9(10):e111474. PubMed ID: 25337860
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Coping with access barriers to non-communicable disease medicines: qualitative patient interviews in eight counties in Kenya.
    Ng G; Raskin E; Wirtz VJ; Banks KP; Laing RO; Kiragu ZW; Rockers PC; Onyango MA
    BMC Health Serv Res; 2021 May; 21(1):417. PubMed ID: 33941177
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Access to medicines through health systems in low- and middle-income countries.
    Ozawa S; Shankar R; Leopold C; Orubu S
    Health Policy Plan; 2019 Dec; 34(Supplement_3):iii1-iii3. PubMed ID: 31816069
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Global status of essential medicine selection: a systematic comparison of national essential medicine lists with recommendations by WHO.
    Piggott T; Nowak A; Brignardello-Petersen R; Cooke GS; Huttner B; Schünemann HJ; Persaud N; Magrini N; Moja L
    BMJ Open; 2022 Feb; 12(2):e053349. PubMed ID: 35144950
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Capacity of Ugandan public sector health facilities to prevent and control non-communicable diseases: an assessment based upon WHO-PEN standards.
    Rogers HE; Akiteng AR; Mutungi G; Ettinger AS; Schwartz JI
    BMC Health Serv Res; 2018 Aug; 18(1):606. PubMed ID: 30081898
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Defining Essential Childhood Cancer Medicines to Inform Prioritization and Access: Results From an International, Cross-Sectional Survey.
    Denburg AE; Fundytus A; Khan MS; Howard SC; Antillon-Klussmann F; Sengar M; Lombe D; Hopman W; Jalink M; Gyawali B; Trapani D; Roitberg F; De Vries EGE; Moja L; Ilbawi A; Sullivan R; Booth CM
    JCO Glob Oncol; 2022 Jun; 8():e2200034. PubMed ID: 35749676
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Selection of essential medicines for diabetes in low and middle income countries: a survey of 32 national essential medicines lists.
    Bazargani YT; de Boer A; Leufkens HG; Mantel-Teeuwisse AK
    PLoS One; 2014; 9(9):e106072. PubMed ID: 25259517
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expanding medicines for neurologic disorders on the WHO Model List.
    Rimmer K; Shah H; Thakur K
    Neurology; 2017 Mar; 88(10):e87-e91. PubMed ID: 28265046
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.